Login
Adgang til udbud
Kontakt os
63 13 37 00
Danmark
Danmark
Deutschland
Eesti
Latvija
Lietuva
Norge
Polska
Russia
Suomi
Sverige
World
UK & Ireland
USA
Nederland
България
Danmark
Danmark
Deutschland
Eesti
Latvija
Lietuva
Norge
Polska
Russia
Suomi
Sverige
World
UK & Ireland
USA
Nederland
България
Kontakt os
Login
Toggle navigation
Support
Mercell Danmark Kundeservice
Mercell CTM Dansk Kundeservice (tidligere EU-Supply)
Mercell Udbudsvagten Kundeservice
Mercell Ethics Kundeservice
Mercell Customer Service - TrueLink
Mercell Customer Service - Comcare
Mercell Customer Service DK (P2P)
Mercell Source-to-Contract Danmark
Søg udbud
Hjemmesiden
Udbud
AI-tool for prostate pathology at St. Olavs Hospital Trust
Information
Bekendtgørelsestype
 
Type
Procedure
 
Forventet opstart af tilbudsprocessen
Forventet slutdato for tilbudsprocessen
Offentliggørelse
27-06-2025 08:54 (GMT+02:00)
Tidsfrist
09-07-2025 12:00 (GMT+02:00)
Spørgefrist
Anbefalet dokumentfrist
Accepterer alternative tilbud
Nej
Accepterer alternative tilbud
Nej
Indkøber
Ordregiver
SYKEHUSINNKJØP HF
SYKEHUSINNKJØP HF
Afdeling
Kontakt
Frida Rekstad
Frida Rekstad
Addresse
Postboks 40
Tollbugata 7
9811
VADSØ
Norge
CVR nr
916879067
Hjemmeside
www.sykehusinnkjop.no
Tidsfristen er overskredet
Kort beskrivelse
Helse Midt-Norge (Central Norway Health Authority) is the first region in Norway to use digital pathology for routine diagnostics in pathology.
The two pathology departments, St. Olavs Hospital and Ålesund sykehus, use the same scanners (Hamamatsu and Philips), the same laboratory information and management system (LIMS, Sympathy) and image management system (IMS, Philips).
Currently many different AI tools and image analyses software packages have been CE-IVD approved for use in clinical routine practice, but until now very few pathology departments have implemented these computer-aided diagnostic (CAD) tools in daily clinical practice.
The two pathology departments in Helse Midt-Norge aim to implement AI tools to enhance the efficiency, speed and objectivity of pathology diagnostics. More importantly, patients will benefit from superior tissue diagnostics that forms the basis for personalized treatment.
To start the AI-tool journey the short-term goal is to purchase and implement an AI tool for automatic detection and grading of prostate cancer. Helse Midt-Norge’s IT organisation, Hemit HF, will be an important partner for successful integration with our IMS.
Dette er tilbudsfasen af en 2 trins opgave, hvor du kan finde informationer om prækalifikationen og evt. filer på dette link:
Qualification: AI-tool for prostate pathology at St. Olavs Hospital Trust
Mercell A/S
En del af Mercell, en af Europas ledende aktører inden for formidling af information mellem indkøber og leverandør på det professionelle marked. CVR nr. 25698851
+45 63 13 37 00
Mercell A/S
|
B!NGS
Vesterbrogade 149
,
1620
København V
,
Danmark
Privatlivspolitik
|
Cookies
|
Vilkår og betingelser
|
Kontakt os
|
Login